Verano Holdings Corp. (VRNOF)
(Delayed Data from OTC)
$3.15 USD
-0.10 (-3.08%)
Updated Sep 6, 2024 03:59 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Verano Holdings Corp. [VRNOF]
Reports for Purchase
Showing records 1 - 20 ( 156 total )
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
2Q24 Results In-Line, Margin Expansion While Building for Growth
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Wholesale Underpins Solid Q2/24 Results, Verano Gets Aggressive on FL
Provider: Ventum Capital Markets
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
2Q24 Preview, In-Line Expectations,Margin Lift as OH Scales
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Acquisitions Add VA to Growth Pipeline and Bolsters AZ Business
Provider: Ventum Capital Markets
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
U.S. Cannabis Industry: 2Q24 Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
1Q24 Mixed, Margins Remain Strong Generating Cash Flow
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Solid Q124 Print, Verano Awaiting Federal and State Catalysts Before Deciding What to Do with its War Chest
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
Cannabis ReHash: DEA Intends to Move to Schedule 3, Investors Not Pricing It In
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
US Cannabis Sector - The Smoke has Lifted! DEA Appears Poised to Publish Schedule III Ruling
Provider: Echelon Welath Partners
Analyst: Research Department